文献速递肾小球疾病

循环补体因子H相关蛋白1和5与IgA肾病疾病活动度相关

Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
PubMed 文献 · Kidney Int · 2017-06-30

该研究基于大型IgA肾病患者队列,发现血浆FHR-1及其与fH比值升高且与疾病进展相关,FHR-1与eGFR负相关;血清FHR-5仅轻度升高且与eGFR无关,但较高FHR-5与免疫抑制无反应、内皮细胞增生及MEST评分严重相关。

要点

  • 血浆FHR-1和FHR-1/fH比值在IgA肾病中升高并与疾病进展相关。
  • FHR-1与eGFR负相关,但在eGFR正常的IgA肾病患者中仍升高。
  • 较高血清FHR-5与免疫抑制治疗无反应及严重组织学表现相关。

核心结论

  • FHR-1和FHR-5在IgA肾病疾病进展中具有一定作用。

研究设计与样本

  • 基于大型IgA肾病患者队列的观察性研究。

主要发现

  • 血浆FHR-1及FHR-1/fH比值在IgA肾病中升高,且与进行性疾病相关。
  • 血浆FHR-1与eGFR负相关,但在eGFR正常的IgA肾病患者中仍升高。
  • 血清FHR-5在IgA肾病中轻度升高,但与eGFR不相关。
  • FHR-5水平及FHR-5/fH比值均与进行性疾病无关。
  • 较高血清FHR-5水平与免疫抑制无反应、内皮细胞增生及Oxford分类MEST评分严重相关。

临床怎么用

  • 检测血浆FHR-1及FHR-1/fH比值可能有助于识别IgA肾病进展风险。
  • 血清FHR-5水平或可提示免疫抑制治疗反应及组织学严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IgA nephropathy (IgAN) is a common cause of chronic kidney disease and end-stage renal failure, especially in young people. Due to a wide range of clinical outcomes and difficulty in predicting response to immunosuppression, we need to understand why and identify which patients with IgAN will develop progressive renal impairment. A deletion polymorphism affecting the genes encoding the complement factor H-related protein (FHR)-1 and FHR-3 is robustly associated with protection against IgAN. Some FHR proteins, including FHR-1 and FHR-5, antagonize the ability of complement factor H (fH), the major negative regulator of the complement alternative pathway, to inhibit complement activation on surfaces, a process termed fH deregulation. From a large cohort of patients, we demonstrated that plasma FHR-1 and the FHR-1/fH ratio were elevated in IgAN and associated with progressive disease. Plasma FHR-1 negatively correlated with eGFR but remained elevated in patients with IgAN with normal eGFR. Serum FHR5 was slightly elevated in IgAN but did not correlate with eGFR. Neither FHR5 levels nor the FHR-5/fH ratio was associated with progressive disease. However, higher serum FHR-5 levels were associated with a lack of response to immunosuppression, the presence of endocapillary hypercellularity, and histology scores of disease severity (the Oxford Classification MEST score). Thus, FHR-1 and FHR-5 have a role in IgAN disease progression.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Medjeral-Thomas NR, Lomax-Browne HJ, Beckwith H, et al. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy. Kidney Int. 2017. PMID: 28673452. doi:10.1016/j.kint.2017.03.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。